Hydroxychloroquine, Azithromycin in the Treatment of Covid-19
NCT04405921
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
SARS-CoV-2 Pneumonia
COVID-19
Interventions
DRUG:
Hydroxychloroquine 200 Mg Oral Tablet
DRUG:
Azithromycin 250 MG
Sponsor
Centre Hôpital Universitaire Farhat Hached